Understanding how chromatin modifications affect gene regulation
Molecular Mechanisms of Chromatin Recognition
This study is looking at how changes to the structure of DNA can affect how genes work and how our cells fix themselves, which could help us understand diseases like cancer better and find new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11117007 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms by which modifications to chromatin influence genomic processes such as gene expression and DNA repair. By using specially designed nucleosomes with specific chemical modifications, the study aims to uncover how these modifications interact with proteins that read and interpret these signals. This approach could reveal new insights into the regulation of cellular identity and integrity, particularly in the context of diseases like cancer. The findings may lead to the development of targeted therapies that address misregulation in these critical processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancers or developmental disorders that may be influenced by chromatin signaling pathways.
Not a fit: Patients with conditions unrelated to chromatin modifications or those not affected by genomic regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating cancers and other diseases linked to chromatin misregulation.
How similar studies have performed: Previous research has shown promising results in understanding chromatin modifications and their implications in various diseases, suggesting that this approach has the potential for significant breakthroughs.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Mcginty, Robert — Univ of North Carolina Chapel Hill
- Study coordinator: Mcginty, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.